about
Revisiting AMPA receptors as an antiepileptic drug targetThe science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future successSynergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult WormsProtective effects of iptakalim, a novel ATP-sensitive potassium channel opener, on global cerebral ischemia-evoked insult in gerbils.Potent and selective inhibition of the open-channel conformation of AMPA receptors by an RNA aptamer.Selective excitatory actions of DNQX and CNQX in rat thalamic neurons.Potent and selective inhibition of a single alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit by an RNA aptamer.Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal modelsIdentification of novel modulators for ionotropic glutamate receptor, iGluA2 by in-silico screeningEGAR, A Food Protein-Derived Tetrapeptide, Reduces Seizure Activity in Pentylenetetrazole-Induced Epilepsy Models Through α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptors.Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possiblyIonotropic glutamate receptors & CNS disorders.AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.New AMPA antagonists in epilepsy.The discovery and development of perampanel for the treatment of epilepsy.The AMPAR Antagonist Perampanel Attenuates Traumatic Brain Injury Through Anti-Oxidative and Anti-Inflammatory Activity.AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after strokePerampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy.Distinct amygdalar AMPAergic/GABAergic mechanisms promote anxiolitic-like effects in an unpredictable stress model of the hamster.
P2860
Q24611163-48B73453-FB46-48EB-A1B4-D8D641EDB260Q28394257-7718D377-39AC-41E2-8AF9-6B4827849FDFQ28548401-FE9849EC-E4B4-41F6-BABC-FCB5227AF820Q33244613-5712676E-9AA9-46BE-8831-08D52D41B23DQ33592457-86A1944D-C3C4-4FA9-8A22-C1ECD4B9697BQ33783879-971C6BA0-9C42-43D9-AE83-E89919255E5BQ33845611-E19D7D03-8689-4DE3-BA86-538973DF9368Q34580749-8E715061-7AC0-46F2-BE28-225674F23F14Q34820857-8F8104B1-92E4-4669-AE7E-85DB4A0CAB14Q36174777-93154615-0B47-4B64-819E-F990EFC35D80Q37024492-07D3BF6B-053F-45F3-AE9F-F2A8EBAE4C14Q37143580-B6CD3ED0-08F4-4BFD-8056-EE9CFF77BA23Q38019570-A0859A1E-7F76-4325-8269-21FD9B57F4E1Q38025721-860F08B9-9DDF-4045-BB31-EAC5D28E9D46Q38190084-53057BEF-17D9-4A17-8B50-AE3329BC6C21Q39992509-4C6127F9-ECAF-47A8-8477-76401F02333BQ41344359-31492314-C6F2-4793-9669-2DA1D69CEB73Q44721490-BCFD919B-48EB-4BA6-B192-6659D714D22DQ47840867-9988436D-9CF1-4FAF-AD68-D28E17CBFF5A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
AMPA receptor antagonists for the treatment of stroke.
@ast
AMPA receptor antagonists for the treatment of stroke.
@en
AMPA receptor antagonists for the treatment of stroke.
@nl
type
label
AMPA receptor antagonists for the treatment of stroke.
@ast
AMPA receptor antagonists for the treatment of stroke.
@en
AMPA receptor antagonists for the treatment of stroke.
@nl
prefLabel
AMPA receptor antagonists for the treatment of stroke.
@ast
AMPA receptor antagonists for the treatment of stroke.
@en
AMPA receptor antagonists for the treatment of stroke.
@nl
P356
P1476
AMPA receptor antagonists for the treatment of stroke.
@en
P2093
Thomas Weiser
P304
P356
10.2174/1568007053544129
P577
2005-04-01T00:00:00Z